bpc-157 fda warning not approved for human use Approval Status: Is It Use? Regeneration or Risk? A Narrative
Description
But its important to know about possible side effects and precautions

The peptide contains an N-terminal acetylation that differs from the naturally occurring form

Severe or prolonged pain doesnt respond to over-the-counter treatments

Myokymia associated with Guillain-Barr syndrome is transient, whereas that associated with multiple sclerosis is also transient, but can recur